HUTCHMED DRC
Price & Volume
Stats
See more52W Range | $9.77-$16.40 |
Market Cap | $2.4B |
Shares Short | 230,030 |
Financials
See moreRevenue (12 Mos) | $549.1M |
Revenue Growth (YoY) | 0.2% |
Gross Profit (12 Mos) | $73.1M |
Diluted EPS | $0.10 |
News
See moreYahoo Finance • 5 days ago
Chinese biopharma stocks rally as U.S. signals openness to drug licensing
Yahoo Finance • 23 days ago
HUTCHMED Lands GSK Deal Worth Up to $1.3B for KRAS-EGFR Cancer Therapy
Yahoo Finance • 23 days ago
HUTCHMED jumps 15% after licensing cancer therapy to GSK for up to $1.295B
Yahoo Finance • 23 days ago
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
About
CEO | Mr. Chig Fung Cheng BEc, CA |
CFO | Mr. Chig Fung Cheng BEc, CA |
Address | Cheung Kong Center, Hong Kong, Hong Kong |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,790 |